Keith Tipton is an accomplished diagnostic imaging industry executive with 14 years at Philips Healthcare prior to joining QI, the last three years with the incubator Women’s Health business. He also has startup experience which led to IPO and M&A experience.
Scientific Advisor, Co-founder
Dr. Maryellen Giger’s career spans more than 25 years of research in computer-aided diagnosis and quantitative image analysis in breast cancer, lung cancer, and bone diseases leading to over 150 peer-reviewed publications and 39 patents. The patented technology upon which QuantX is based was developed in Dr. Giger’s labs.
Medical Advisor, Co-founder
Dr. Gillian Newstead is past Chief of Breast Imaging at the University of Chicago. A recognized global expert in multimodal assessment and quantitative analysis of breast cancer, she currently conducts translational research into novel methods of analysis of breast MRI, ultrasound and mammographic images.
Robert Tomek spent eight years working closely with Dr. Giger developing novel algorithms to enhance diagnosis from complex medical images. This work led to several patents, many of which are licensed by QI.
Former GM at OK Cupid Labs. He also helped to start Excelerate Labs, which recently became Techstars Chicago. Brian is a Kauffman Fellow (Class 18) and holds an MBA from The University of Chicago.